Neuronal microtubules and proteins linked to Parkinson’s disease: a relevant interaction?
Author:
Calogero Alessandra M.1, Mazzetti Samanta12, Pezzoli Gianni23, Cappelletti Graziella14ORCID
Affiliation:
1. Department of Biosciences , Università degli Studi di Milano , via Celoria 26 , I-20133 Milan , Italy 2. Fondazione Grigioni per il Morbo di Parkinson , via Zuretti 35 , I-20135 Milan , Italy 3. Parkinson Institute, ASST “G.Pini-CTO” , via Bignami 1 , I-20133 Milan , Italy 4. Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano , via Balzaretti , I-20133 Milan , Italy
Abstract
Abstract
Neuronal microtubules are key determinants of cell morphology, differentiation, migration and polarity, and contribute to intracellular trafficking along axons and dendrites. Microtubules are strictly regulated and alterations in their dynamics can lead to catastrophic effects in the neuron. Indeed, the importance of the microtubule cytoskeleton in many human diseases is emerging. Remarkably, a growing body of evidence indicates that microtubule defects could be linked to Parkinson’s disease pathogenesis. Only a few of the causes of the progressive neuronal loss underlying this disorder have been identified. They include gene mutations and toxin exposure, but the trigger leading to neurodegeneration is still unknown. In this scenario, the evidence showing that mutated proteins in Parkinson’s disease are involved in the regulation of the microtubule cytoskeleton is intriguing. Here, we focus on α-Synuclein, Parkin and Leucine-rich repeat kinase 2 (LRRK2), the three main proteins linked to the familial forms of the disease. The aim is to dissect their interaction with tubulin and microtubules in both physiological and pathological conditions, in which these proteins are overexpressed, mutated or absent. We highlight the relevance of such an interaction and suggest that these proteins could trigger neurodegeneration via defective regulation of the microtubule cytoskeleton.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference124 articles.
1. Alim, M.A., Hossain, M.S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S., and Uéda, K. (2002). Tubulin seeds α-synuclein fibril formation. J. Biol. Chem. 277, 2112–2117. 2. Alim, M.A., Ma, Q.L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M., et al. (2004). Demonstration of a role for α-synuclein as a functional microtubule-associated protein. J. Alzheimers Dis. 6, 435–442. 3. Alves da Costa, C., Duplan, E., Rouland, L., and Checler, F. (2019). The transcription factor function of parkin: breaking the dogma. Front Neurosci. 12, 965. 4. Appel-Cresswell, S., Vilarino-Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu-Tu, C., Trinh, J., et al. (2013). Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov. Disord. 28, 811–813. 5. Auluck, P.K., Caraveo, G., and Lindquist, S. (2010). α-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu. Rev. Cell Dev. Biol. 26, 211–233.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|